In brief
Attorney teams for Luigi Mangione, charged with killing United Healthcare CEO Brian Thompson, convened with federal prosecutors on Friday to discuss a potential plea deal. The case involves two stalking‑related federal charges that could lead to life imprison tion, yet prosecutors have not disclosed which charges are on the table. If a federal plea is entered, it may trigger New York’s double‑jeopardy law, jeopardizing the separate state trial scheduled for September. The outcome could affect both the length of potential sentences and the legal strategy of Mangione’s defense team.
Attorneys for Luigi Mangione, who is accused of killing United Healthcare CEO Brian Thompson in New York, are meeting federal prosecutors on Friday amid US media reports of a possible plea agreement.
Mangione faces two federal stalking charges that could carry life in prison each. The specific charges under negotiation have not yet been disclosed.
"There’s a conference scheduled for 11 am on Friday, and that is all we can say at this time," said Jamie McDonald, the US Attorney for the Southern District of New York.
Mangione also faces a separate state trial over Thompson’s death and has pleaded not guilty in both cases.
A plea deal is not guaranteed; such agreements may unravel before finalization and require court approval via a separate hearing to enter the new plea.
Federal prosecutors argue that Mangione traveled between states and performed electronic surveillance with the intent to kill or harm Thompson, actions that allegedly led to Thompson’s death.
In January, a federal judge dismissed two other charges, including murder by firearm which could have invoked the death penalty.
The attorneys, the SDNY, and Manhattan District Attorney’s office have not responded to comment requests.
Mangione’s team has previously contended that he should not be prosecuted in both state and federal courts, though judges have allowed both proceedings to proceed.
Should Mangione plead guilty federally, his attorneys could argue that the state case violates New York’s double‑jeopardy prohibition, potentially invalidating the state trial.
"If a federal prosecution has been completed on a matter, the state cannot prosecute the matter on those same facts," said Mitchell Epner, a white‑collar attorney.
The fate of the state case under such an outcome remains uncertain.
Mark Chutkow, a white‑collar defense lawyer at Dkyema Law, described the situation as “a live issue.” He added that the state trial judge would have to decide if charges overlap sufficiently to invoke the double‑jeopardy statute, while Manhattan prosecutors might assert that the state case is distinct enough to continue.
Mangione’s state trial is set for 8 September, while the federal trial is scheduled for January 2027.
